Replimune Group, Inc.
REPL · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $1 | $0 |
| Gross Profit | $0 | $0 | -$1 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $58 | $58 | $55 | $48 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $0 | $0 | $25 | $0 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $26 | $33 | $0 | $18 |
| Operating Expenses | $84 | $90 | $79 | $66 |
| Operating Income | -$84 | -$90 | -$80 | -$66 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $1 | $4 | $5 | $0 |
| Pre-Tax Income | -$83 | -$87 | -$75 | -$66 |
| Tax Expense | $0 | $0 | -$1 | $1 |
| Net Income | -$83 | -$87 | -$74 | -$66 |
| % Margin | – | – | – | – |
| EPS | -0.9 | -0.95 | -0.96 | -0.79 |
| % Growth | 5.3% | 1% | -21.5% | – |
| EPS Diluted | -0.9 | -0.95 | -0.96 | -0.79 |
| Weighted Avg Shares Out | 92 | 92 | 81 | 83 |
| Weighted Avg Shares Out Dil | 92 | 92 | 81 | 83 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $6 | $0 |
| Interest Expense | $1 | $2 | $2 | $2 |
| Depreciation & Amortization | $1 | $1 | $1 | $1 |
| EBITDA | -$82 | -$89 | -$72 | -$65 |
| % Margin | – | – | – | – |